Wednesday, January 12, 2022

CDC: Two COVID-Related COCA Calls This Week (12th & 13th)



#16,503

The CDC will hold the first two  COCA (Clinician Outreach & Communication Activity) Calls of 2022 today and tomorrow (Jan 12th & 13th), on the following COVID-related topics.

COCA Call: January 12, 2022: What Clinicians Need to Know About the New Oral Antiviral Medications for COVID-19 

COCA Call: January 13, 2022: Updates to CDC’s COVID-19 Quarantine and Isolation Guidelines in Healthcare and Non-healthcare Settings

COCA Calls are essentially 1-hour webinars. These presentations are often technical, and are of greatest interest to clinicians and healthcare providers, but also may be of interest to the general public. 

As always, If you are unable to attend the live presentation, these (and past) webinars are archived and available for later viewing at this LINK.

Details on these upcoming presentations follow:

Today (January 12th):



Overview

The emergency use authorizations (EUAs) for the new oral antiviral medications molnupiravir and Paxlovid™ (nirmatrelvir/ritonavir) supplement current therapeutic efforts to decrease hospitalizations and prevent severe COVID-19 and death. During this COCA Call, presenters from the Centers for Disease Control and Prevention (CDC), Office of the Assistant Secretary for Preparedness and Response, U.S. Food and Drug Administration (FDA), and the National Institutes of Health (NIH) will describe the recent EUAs and NIH treatment guidelines, patient prioritization, and resources for healthcare providers. Subject matter experts will review when to prescribe antiviral medications including patient assessment, how to have a risk-benefit discussion to address patient questions or concerns, and how to prioritize patients if medications are in short supply.

Presenters

Lauri Hicks, DO
Captain, US Public Health Service
Chief Medical Officer, COVID-19 Response
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention

Colin Shepard, MD
CDC Liaison to the Assistant Secretary for Preparedness and Response (ASPR)
Center for Preparedness and Response
Centers for Disease Control and Prevention

Stephanie Troy, MD
Senior Medical Officer
Division of Antivirals
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Aimee Hodowanec, MD
Senior Medical Officer
Division of Antivirals
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Alice K. Pau, PharmD
Executive Secretary, NIH COVID-19 Treatment Guidelines Panel
Staff Scientist (Clinical)
Clinical Pharmacy Specialist
Division of Clinical Research
National Institute of Allergy & Infectious Diseases
National Institutes of Health


Call Details

When:
Wednesday, January 12, 2022,
2:00 PM – 3:00 PM ET

Webinar Link:

Webinar ID: 161 297 4214

Passcode: 180866

Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 551 285 1373
or +1 669 216 1590


One-tap mobile:
US: +16692545252,,1612974214#,,,,*180866# or +16468287666,,1612974214#,,,,*180866#


Tomorrow (January 13th): 

Updates to CDC’s COVID-19 Quarantine and Isolation Guidelines in Healthcare and Non-healthcare Settings

Overview

The Centers for Disease Control and Prevention (CDC) has recently updated COVID-19 quarantine and isolation recommendations for healthcare and non-healthcare settings. During this COCA Call, presenters will discuss the science supporting these changes, the populations and settings to which these changes apply, and additional precautions people should take at the end of quarantine or isolation.

Presenters

Lauri Hicks, DO
Captain, U.S. Public Health Service
Chief Medical Officer, COVID-19 Response
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention

Alexander Kallen, MD, MPH
Chief, Prevention and Response Branch
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention

Pragna Patel, MD, MPH
Deputy Principal Incident Manager, COVID-19 Response
Senior Medical and Science Advisor, HIV Prevention Branch
Division of Global HIV and TB
Centers for Disease Control and Prevention

Call Details

When:
Thursday, January 13, 2022,
2:00 PM – 3:00 PM ET

Webinar Link:
https://www.zoomgov.com/j/1610664006 
Webinar ID: 161 066 4006

Passcode: 468334

Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 551 285 1373
or +1 669 216 1590

International numbers 

One-tap mobile:
US: +16692545252,,1610664006#,,,,*468334# or +16468287666,,1610664006#,,,,*468334#
Posted by at